DeepMed Research

Natera

🇺🇸United States

Country: 🇺🇸United States

Ownership: Public

Established: 2004-01-01

Employees: 3K

Market Cap: -

Website: http://www.natera.com

Introduction: Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT). The company was founded by Matthew Rabinowitz and Jonathan Sheena in November 2003 and is headquartered in Austin, TX.

Clinical Trials

EXpanding Prenatal Cell Free DNA Screening Across MoNogenic Disorders (EXPAND)

Recruiting

Conditions: Single Gene NIPT

First Posted Date: 2025-03-25

Last Posted Date: 2025-03-25

Lead Sponsor: Natera, Inc.

Target Recruit Count: 4000

Registration Number: NCT06808880

Locations: 🇺🇸
Valley Perinatal, Glendale, Arizona, United States
🇺🇸
Cedars Sinai Prenatal Diagnosis Center, Los Angeles, California, United States
🇺🇸
Center for Fetal Medicine and Womens Ultrasound, Los Angeles, California, United States

and more 17 locations

Prospective Collection of Samples to Enable the Development of Natera Screening Assay for Early Cancer Detection

Recruiting

Conditions: Colorectal Cancer Screening

First Posted Date: 2024-10-01

Last Posted Date: 2025-01-29

Lead Sponsor: Natera, Inc.

Target Recruit Count: 5000

Registration Number: NCT06620627

Locations: 🇺🇸
Natera, Austin, Texas, United States

A Comparative Effectiveness Study in Heart Transplant Patients of Rejection Surveillance With Cell-free DNA Versus Endomyocardial Biopsy

Not Applicable

Recruiting

Conditions: Heart Transplant Failure and Rejection

Interventions: Diagnostic Test: The Prospera™ Test

First Posted Date: 2024-05-16

Last Posted Date: 2025-04-02

Lead Sponsor: Natera, Inc.

Target Recruit Count: 250

Registration Number: NCT06414603

Locations: 🇺🇸
Cedars-Sinai Medical Center, Los Angeles, California, United States
🇺🇸
University of California, San Diego, San Diego, California, United States
🇺🇸
University of Colorado, Aurora, Colorado, United States

and more 8 locations

Renasight Clinical Application, Review and Evaluation (RenaCARE) Study

Not Applicable

Active, not recruiting

Conditions: Kidney Diseases

Interventions: Diagnostic Test: Renasight

First Posted Date: 2023-05-06

Last Posted Date: 2023-09-28

Lead Sponsor: Natera, Inc.

Target Recruit Count: 1720

Registration Number: NCT05846113

Locations: 🇺🇸
Southeastern Clinical Research Institute, LLC, Augusta, Georgia, United States
🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States
🇺🇸
University of Pittsburgh Medical Center (UPMC), Pittsburgh, Pennsylvania, United States

and more 28 locations

Clinical Utility of the Addition of a SNP-based NIPT Zygosity Determination in Twin Pregnancy Management.

Completed

Conditions: Pregnancy Complications
Multiple Gestation; Maternal Care
Twin to Twin Transfusion Syndrome

First Posted Date: 2022-04-06

Last Posted Date: 2023-11-13

Lead Sponsor: Natera, Inc.

Target Recruit Count: 137

Registration Number: NCT05312814

Locations: 🇺🇸
Rady Children Specialists of San Diego, San Diego Perinatal Center, San Diego, California, United States
🇺🇸
University of Colorado, Aurora, Colorado, United States
🇺🇸
Anne Arundel Medical Center/Luminis Health, Annapolis, Maryland, United States

and more 5 locations

Development of Non-invasive Cell-free DNA to Supplant Invasive Biopsy in Heart Transplantation

Completed

Conditions: Heart Transplant

First Posted Date: 2022-04-04

Last Posted Date: 2024-10-29

Lead Sponsor: Natera, Inc.

Target Recruit Count: 147

Registration Number: NCT05309382

Locations: 🇺🇸
University of California, San Diego, San Diego, California, United States
🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
🇺🇸
University of Utah, Salt Lake City, Utah, United States

and more 6 locations

Prospera Test Evaluation in Cardiac Transplant (ProTECT)

Active, not recruiting

Conditions: Heart Transplant Rejection

First Posted Date: 2022-01-25

Last Posted Date: 2024-03-20

Lead Sponsor: Natera, Inc.

Target Recruit Count: 411

Registration Number: NCT05205551

Locations: 🇺🇸
Natera, San Carlos, California, United States

LAMBDA 002 (Lung Registry) Study

Active, not recruiting

Conditions: Lung Transplant Rejection

Interventions: Device: Prospera

First Posted Date: 2021-12-28

Last Posted Date: 2025-04-02

Lead Sponsor: Natera, Inc.

Target Recruit Count: 154

Registration Number: NCT05170425

Locations: 🇺🇸
Northwestern Memorial Hospital, Chicago, Illinois, United States
🇺🇸
Houston Methodist Hospital, Houston, Texas, United States
🇺🇸
University of Washington, Seattle, Washington, United States

and more 8 locations

Donor-Derived Cell-free DNA to DETect REjection in Cardiac Transplantation

Not Applicable

Withdrawn

Conditions: Heart Transplant Failure and Rejection

Interventions: Procedure: Endomyocardial biopsy
Diagnostic Test: Prospera Transplant Assessment

First Posted Date: 2021-10-18

Last Posted Date: 2024-04-03

Lead Sponsor: Natera, Inc.

Registration Number: NCT05081739

Verification of Risk Assignment for Whole Chromosome Using SNP-based NIPT in Vanishing Twin Pregnancies

Completed

Conditions: Vanishing Twin
Trisomy 13
Trisomy 18
Trisomy 21

First Posted Date: 2021-08-13

Last Posted Date: 2023-12-15

Lead Sponsor: Natera, Inc.

Target Recruit Count: 126

Registration Number: NCT05004337

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States
🇺🇸
Hackensack, Neptune, New Jersey, United States
🇺🇸
Beaumont, Royal Oak, Michigan, United States

and more 18 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy